Fundamental Analysis
48 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +4.9% | +43.6% | 3 / 3 | +5.9% | -6.73 pp | -0.87 pp | +15.5% | 0.73 | 10.23 | 367 | +5,9% | 35,8 | −2,8% | 10.23 | 14.01 | −27,0% |
| Pts | 0 | 8 | 12 | 0 | 0 | 4 | 4 | 12 | 12 | |||||||
Valuation annotation:Price: 23.000 (close price on 2026-10-15)EPS (TTM): 2.249
Financial charts
1.Revenue & growth
VND bn367Q2/26
1.Revenue & growth
VND bn367Q2/26
2.Profit & growth
VND bn30,9Q2/26
3.Profit mix (Penman)
VND bn211Q2/26
4.Margins & cost structure
%37.2%Q2/26
5.Returns & cash cycle
% · days14.8%Q2/26
6.Earnings quality & cash
VND bn330Q2/26
7.Asset structure
VND bn2.088Q2/26
8.Funding & debt health
VND bn · times2.088Q2/26
9.Revenue backlog
VND bn2,31Q2/26
10.Valuation
times · %10,5×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %417Q2/26
Adjusted EPS growth, latest quarter
-9.4%
Average adjusted EPS growth, 3 quarters
38.8%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26